This report contains market size and forecasts of Antihemophilic Factor in global, including the following market information:
Global Antihemophilic Factor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antihemophilic Factor Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Antihemophilic Factor companies in 2021 (%)
The global Antihemophilic Factor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antihemophilic Factor include Biogen Idec, Bayer, Octapharma, Novo Nordisk, Baxter, Genetics Institute and Wyeth Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antihemophilic Factor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihemophilic Factor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Antihemophilic Factor Market Segment Percentages, by Type, 2021 (%)
Powder
Liquid
Global Antihemophilic Factor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Antihemophilic Factor Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Antihemophilic Factor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Antihemophilic Factor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antihemophilic Factor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antihemophilic Factor revenues share in global market, 2021 (%)
Key companies Antihemophilic Factor sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Antihemophilic Factor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen Idec
Bayer
Octapharma
Novo Nordisk
Baxter
Genetics Institute
Wyeth Pharmaceuticals